Thorne HealthTech Overview
Pro stress-test →Thorne HealthTech is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals and corporations. The firm's brands, Thorne and Onegevity, provide insights and personalized data, products and services. The company is trusted by more than four million customers, 45,000 health professionals, thousands of professional athletes, and more than 100 professional sports teams.
Strategic Profile
Pro stress-test →In October 2023, L Catterton, a global consumer-focused private equity firm, completed its acquisition of Thorne HealthTech for approximately $680 million, resulting in Thorne's delisting from the NASDAQ. As of December 2025, Thorne HealthTech's revenue was $410.5 million USD, with revenue growth of 17% over the last year. The company leverages vertical integration across consumer supplements, health diagnostics, and personalized wellness technologies to compete in the premium preventive health market.
Competitive Landscape
Pro stress-test →Key competitors include Ortho Molecular Products, Metagenics, Xymogen, Physician's Choice, and Designs for Health. Additional competitors noted include Gainful, bioniq, and Thesis. Thorne competes across three overlapping segments: premium nutritional supplements (versus clinical brands and mass-market players), at-home health diagnostics (versus Quest, LabCorp, Everlywell), and personalized wellness services (versus Ro, Amazon Pharmacy, and telehealth platforms).
Industry Context
Thorne HealthTech operates in Nutritional supplements and personalized health diagnostics.
Key facts
Founded: 1984 · Headquarters: Summerville, South Carolina · Employees: 496 · Revenue: $410.5M (as of December 2025)